Disc Medicine, Inc.
General ticker "IRON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.9B (TTM average)
Disc Medicine, Inc. follows the US Stock Market performance with the rate: 60.8%.
Estimated limits based on current volatility of 2.2%: low 90.26$, high 94.37$
Factors to consider:
- Total employees count: 29 as of 2020
- Current price 28.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [27.36$, 72.60$]
- 2025-12-31 to 2026-12-31 estimated range: [16.09$, 45.66$]
Financial Metrics affecting the IRON estimates:
- Negative: with PPE of -16.0 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.33 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 89.29 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term IRON quotes
Long-term IRON plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $47.48MM | $91.12MM | $129.72MM |
| Operating Income | $-47.48MM | $-91.12MM | $-129.72MM |
| Non-Operating Income | $0.65MM | $14.79MM | $20.72MM |
| Interest Expense | $0.00MM | $0.00MM | $0.57MM |
| R&D Expense | $33.44MM | $69.26MM | $96.67MM |
| Income(Loss) | $-46.83MM | $-76.33MM | $-109.00MM |
| Taxes | $0.00MM | $0.10MM | $0.35MM |
| Profit(Loss)* | $-46.83MM | $-76.43MM | $-109.36MM |
| Stockholders Equity | $176.60MM | $345.12MM | $443.59MM |
| Assets | $200.21MM | $368.00MM | $496.77MM |
| Operating Cash Flow | $-42.25MM | $-73.46MM | $-93.93MM |
| Capital expenditure | $0.15MM | $0.09MM | $0.51MM |
| Investing Cash Flow | $-0.15MM | $-0.09MM | $-292.33MM |
| Financing Cash Flow | $148.98MM | $239.38MM | $218.31MM |
| Earnings Per Share** | $-45.05 | $-3.42 | $-3.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.